Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.990
+0.010 (0.20%)
Feb 27, 2026, 4:00 PM EST - Market closed
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
|---|
The Research, Development and Commercialisation of Health Technologies | 12.51M | 1.96M | 6.21M | 8.83K |
The Research, Development and Commercialisation of Health Technologies Growth | 538.86% | -68.46% | 70218.68% | - |
| 12.51M | 1.96M | 6.21M | 8.83K |
| 538.86% | -68.46% | 70218.68% | - |
Revenue by Geography
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
|---|
| 3.63M | 299.23K | 292.36K | - |
| 1114.27% | 2.35% | - | - |
| - | - | - | 8.83K |
| 3.63M | 299.23K | 292.36K | 8.83K |
| 1114.27% | 2.35% | 3210.60% | - |
Source: S&P Global Market Intelligence.
